Compound Formula Rehmannia Alleviates Levodopa-Induced Dyskinesia in Parkinson's Disease

Levodopa is the preferred treatment in the clinic for Parkinson's disease.

However, long-term use of levodopa may lead to various motor complications, among which levodopa-induced dyskinesia is the most common, severely affecting patients' quality of life.

Drug Firm to Pay Huge Damages to Parkinsons Disease Sufferer
A French Parkinson's sufferer who turned into a gambler and thief, with compulsive homosexual urges thanks to the drugs he took, is all set to receive a huge compensation.

Dr. Jiancheng He and co-workers from Shanghai University of Traditional Chinese Medicine in China established a model of Parkinson's disease dyskinesia in rats, and treated these animals with Compound Formula Rehmannia.

They found that Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease by modulating neurotransmitter signaling in the corpus striatum. The relevant article has been published in the Neural Regeneration Research (Vol. 9, No. 4, 2014).

Source-Eurekalert

Nose may Hold Key to Parkinson's Cure
A new study from Griffith University suggests that Parkinson's patients' nose may harbour a cure for the disease.

Robot Controlled by Cables may Help in Stroke and Parkinson�s Patients
A unique robotic device has been developed by experts at Florida Atlantic University. This robot may prove useful in rehabilitating patients suffering from Parkinson's disease and stroke.

Parkinson Disease at a Younger Age Attributed to Gene Abnormality
According to a study published in the September 18, 2007, issue of Neurology, the medical journal of the American Academy of Neurology, people with a certain gene mutation